• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间充质干细胞与血管紧张素转换酶抑制剂在肾脏修复中的作用

Role of mesenchymal stem cells versus angiotensin converting enzyme inhibitor in kidney repair.

作者信息

Ahmed Hanaa H, Toson Elshahat A, El-Mezayen Hatem A, Rashed Laila A, Elsherbiny Eslam S

机构信息

Hormones Department, National Research Centre, Dokki, Giza, Egypt.

Chemistry Department, Faculty of Science, Damietta University, Damietta, Egypt.

出版信息

Nephrology (Carlton). 2017 Jul;22(7):531-540. doi: 10.1111/nep.12812.

DOI:10.1111/nep.12812
PMID:27162005
Abstract

AIM

The current study sought to clarify the role of bone marrow derived mesenchymal stem cells (BM-MSCs) and adipose tissue derived mesenchymal stem cells (AD-MSCs) in repressing nephropathy in the experimental model. Moreover, the aim of this work was extended to compare between stem cells role and angiotensin converting enzyme inhibitor in kidney repair.

METHODS

Isolation and preparation of MSCs culture, flow cytometry using CD34, CD44 and CD105 cell surface markers, biochemical analyses for determination of serum creatinine, urea, transforming growth factor β (TGF-β), cystatin C (CYS-C) and urinary N-Acetyl-ß-D-Glucosaminidase (UNAG), and histopathological investigation of kidney tissue sections were performed.

RESULTS

The results of the present study revealed that single intravenous infusion of MSCs either derived from bone marrow or adipose tissue was able to enhance renal reparative processes through significantly decreased serum creatinine, urea, TGF-β and CYS-C levels as well as UNAG level and significantly increase glomerular filtration rate. Additionally, the histopathological investigations of kidney tissues showed that MSCs have significant regenerative effects as evidenced by the decrease in focal inflammatory cells infiltration, focal interstitial nephritis and congested glomeruli as well as degenerated tubules.

CONCLUSION

The current data provided distinct evidence about the favourable impact of AD-MSCs and BM-MSCs in attenuation of cyclosporine-induced nephropathy in rats through their ability to promote functional and structural kidney repair via transdifferentiation.

摘要

目的

本研究旨在阐明骨髓间充质干细胞(BM-MSCs)和脂肪组织来源的间充质干细胞(AD-MSCs)在实验模型中抑制肾病的作用。此外,本研究的目的还扩展到比较干细胞与血管紧张素转换酶抑制剂在肾脏修复中的作用。

方法

进行间充质干细胞培养的分离与制备、使用CD34、CD44和CD105细胞表面标志物的流式细胞术、测定血清肌酐、尿素、转化生长因子β(TGF-β)、胱抑素C(CYS-C)和尿N-乙酰-β-D-氨基葡萄糖苷酶(UNAG)的生化分析,以及对肾组织切片进行组织病理学研究。

结果

本研究结果显示,单次静脉输注来源于骨髓或脂肪组织的间充质干细胞能够通过显著降低血清肌酐、尿素、TGF-β和CYS-C水平以及UNAG水平,并显著提高肾小球滤过率来增强肾脏修复过程。此外,肾组织的组织病理学研究表明,间充质干细胞具有显著的再生作用,表现为局灶性炎性细胞浸润、局灶性间质性肾炎、肾小球充血以及肾小管变性减少。

结论

目前的数据提供了明确的证据,表明AD-MSCs和BM-MSCs通过其通过转分化促进肾脏功能和结构修复的能力,对环孢素诱导的大鼠肾病具有减轻作用。

相似文献

1
Role of mesenchymal stem cells versus angiotensin converting enzyme inhibitor in kidney repair.间充质干细胞与血管紧张素转换酶抑制剂在肾脏修复中的作用
Nephrology (Carlton). 2017 Jul;22(7):531-540. doi: 10.1111/nep.12812.
2
Autologous bone marrow-derived mesenchymal stem cells for interstitial fibrosis and tubular atrophy: a pilot study.自体骨髓间充质干细胞治疗肾间质纤维化和肾小管萎缩:一项初步研究。
Ren Fail. 2021 Dec;43(1):1266-1275. doi: 10.1080/0886022X.2021.1968432.
3
Tissue source determines the differentiation potentials of mesenchymal stem cells: a comparative study of human mesenchymal stem cells from bone marrow and adipose tissue.组织来源决定间充质干细胞的分化潜能:骨髓和脂肪组织来源的人骨髓间充质干细胞的比较研究。
Stem Cell Res Ther. 2017 Dec 6;8(1):275. doi: 10.1186/s13287-017-0716-x.
4
Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue.源自骨髓和脂肪组织的间充质干细胞的生物学特性。
J Cell Biochem. 2006 Dec 1;99(5):1285-97. doi: 10.1002/jcb.20904.
5
Clinical-Grade Isolated Human Kidney Perivascular Stromal Cells as an Organotypic Cell Source for Kidney Regenerative Medicine.临床级分离的人肾脏血管周基质细胞作为肾脏再生医学的器官型细胞来源。
Stem Cells Transl Med. 2017 Feb;6(2):405-418. doi: 10.5966/sctm.2016-0053. Epub 2016 Sep 20.
6
Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.在实验性系膜增生性肾小球肾炎中,对血管紧张素II进行药物控制可改善肾脏疾病,同时降低肾脏转化生长因子-β水平。
Am J Kidney Dis. 1998 Mar;31(3):453-63. doi: 10.1053/ajkd.1998.v31.pm9506682.
7
The therapeutic effects of bone marrow-derived mesenchymal stem cells and simvastatin in a rat model of liver fibrosis.骨髓间充质干细胞和辛伐他汀对肝纤维化大鼠模型的治疗作用。
Cell Biochem Biophys. 2014 Jan;68(1):111-25. doi: 10.1007/s12013-013-9698-1.
8
Human peripheral blood derived mesenchymal stem cells demonstrate similar characteristics and chondrogenic differentiation potential to bone marrow derived mesenchymal stem cells.人外周血来源的间充质干细胞表现出与骨髓来源的间充质干细胞相似的特征和软骨分化潜能。
J Orthop Res. 2012 Apr;30(4):634-42. doi: 10.1002/jor.21556. Epub 2011 Sep 15.
9
Mesenchymal Stem Cells: a Promising Therapeutic Tool for Acute Kidney Injury.间充质干细胞:急性肾损伤治疗的有前途的工具。
Appl Biochem Biotechnol. 2019 Sep;189(1):284-304. doi: 10.1007/s12010-019-02995-2. Epub 2019 Apr 12.
10
Comparison of bone marrow and adipose tissue-derived canine mesenchymal stem cells.骨髓和脂肪组织来源的犬间充质干细胞的比较。
BMC Vet Res. 2012 Aug 31;8:150. doi: 10.1186/1746-6148-8-150.

引用本文的文献

1
Stem Cells in Kidney Ischemia: From Inflammation and Fibrosis to Renal Tissue Regeneration.肾脏缺血中的干细胞:从炎症和纤维化到肾脏组织再生。
Int J Mol Sci. 2023 Feb 27;24(5):4631. doi: 10.3390/ijms24054631.